Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Quantitative, Digital, Endpoint), By Product (Consumables & Reagents, Instruments, Software & Services), By Application (Clinical, Research), By Region & Competition, 2021-2031F
The Global Real-time PCR, Digital PCR & End-point PCR Market will grow from USD 9.01 Billion in 2025 to USD 13.12 Billion by 2031 at a 6.46% CAGR. The Global Real-time PCR, Digital PCR & End-point PCR Market comprises advanced nucleic acid amplification technologies utilized for the precise detection and quantification of genetic materials. While real-time PCR enables immediate monitoring and digital PCR provides absolute quantification, end-point PCR remains fundamental for qualitative analysis.
Key Market Drivers
The escalating global prevalence of infectious diseases and genetic disorders acts as a primary catalyst for the market, necessitating high-throughput and highly sensitive diagnostic tools. As the burden of chronic conditions like cancer intensifies, the reliance on real-time and digital PCR for biomarker quantification and genetic mutation analysis has surged to support early detection and personalized treatment strategies.
Key Market Challenges
High instrumentation costs and limited diagnostic infrastructure in developing regions significantly hinder the growth of the Global Real-time PCR, Digital PCR & End-point PCR Market. Advanced molecular platforms require substantial upfront capital for equipment and continuous funding for consumables which proves prohibitive for healthcare systems in low-income areas. These financial barriers prevent the widespread installation of PCR platforms in decentralized laboratories and confine the market largely to well-funded urban centers.
Key Market Trends
The proliferation of multiplex PCR assays for syndromic pathogen detection is significantly altering diagnostic workflows by enabling the simultaneous identification of numerous targets from a single specimen. This trend addresses the inefficiency of serial testing, particularly for complex clinical presentations such as gastrointestinal infections, meningitis, and sepsis, where identifying the specific causative agent rapidly is critical for patient management.
Key Market Players
In this report, the Global Real-time PCR, Digital PCR & End-point PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Real-time PCR, Digital PCR & End-point PCR Market.
Available Customizations:
Global Real-time PCR, Digital PCR & End-point PCR Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The escalating global prevalence of infectious diseases and genetic disorders acts as a primary catalyst for the market, necessitating high-throughput and highly sensitive diagnostic tools. As the burden of chronic conditions like cancer intensifies, the reliance on real-time and digital PCR for biomarker quantification and genetic mutation analysis has surged to support early detection and personalized treatment strategies.
Key Market Challenges
High instrumentation costs and limited diagnostic infrastructure in developing regions significantly hinder the growth of the Global Real-time PCR, Digital PCR & End-point PCR Market. Advanced molecular platforms require substantial upfront capital for equipment and continuous funding for consumables which proves prohibitive for healthcare systems in low-income areas. These financial barriers prevent the widespread installation of PCR platforms in decentralized laboratories and confine the market largely to well-funded urban centers.
Key Market Trends
The proliferation of multiplex PCR assays for syndromic pathogen detection is significantly altering diagnostic workflows by enabling the simultaneous identification of numerous targets from a single specimen. This trend addresses the inefficiency of serial testing, particularly for complex clinical presentations such as gastrointestinal infections, meningitis, and sepsis, where identifying the specific causative agent rapidly is critical for patient management.
Key Market Players
- Abbott Laboratories Inc
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific, Inc.
- BIOMERIEUX SA
- Fluidigm Corporation
- F. Hoffmann-La Roche Ltd
- GE Healthcare
- Agilent Technologies, Inc.
- Qiagen NV
- Microsynth Ag
In this report, the Global Real-time PCR, Digital PCR & End-point PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Real-time PCR, Digital PCR & End-point PCR Market, By Technology:
- Quantitative
- Digital
- Endpoint
- Real-time PCR, Digital PCR & End-point PCR Market, By Product:
- Consumables & Reagents
- Instruments
- Software & Services
- Real-time PCR, Digital PCR & End-point PCR Market, By Application:
- Clinical
- Research
- Real-time PCR, Digital PCR & End-point PCR Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Real-time PCR, Digital PCR & End-point PCR Market.
Available Customizations:
Global Real-time PCR, Digital PCR & End-point PCR Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Quantitative, Digital, Endpoint)
5.2.2. By Product (Consumables & Reagents, Instruments, Software & Services)
5.2.3. By Application (Clinical, Research)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.2. Canada Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.3. Mexico Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Product
6.3.3.2.3. By Application
7. EUROPE REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.2. France Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.3. United Kingdom Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.4. Italy Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.5. Spain Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Product
7.3.5.2.3. By Application
8. ASIA PACIFIC REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.2. India Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.3. Japan Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.4. South Korea Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.5. Australia Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Product
8.3.5.2.3. By Application
9. MIDDLE EAST & AFRICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.2. UAE Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.3. South Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Product
9.3.3.2.3. By Application
10. SOUTH AMERICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Product
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.2. Colombia Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.3. Argentina Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Product
10.3.3.2.3. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Bio-Rad Laboratories Inc.
15.3. Thermo Fisher Scientific, Inc.
15.4. BIOMERIEUX SA
15.5. Fluidigm Corporation
15.6. F. Hoffmann-La Roche Ltd
15.7. GE Healthcare
15.8. Agilent Technologies, Inc.
15.9. Qiagen NV
15.10. Microsynth Ag
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Quantitative, Digital, Endpoint)
5.2.2. By Product (Consumables & Reagents, Instruments, Software & Services)
5.2.3. By Application (Clinical, Research)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. NORTH AMERICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.2. Canada Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.3. Mexico Real-time PCR, Digital PCR & End-point PCR Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Product
6.3.3.2.3. By Application
7. EUROPE REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.2. France Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.3. United Kingdom Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.4. Italy Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.5. Spain Real-time PCR, Digital PCR & End-point PCR Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Product
7.3.5.2.3. By Application
8. ASIA PACIFIC REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.2. India Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.3. Japan Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.4. South Korea Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.5. Australia Real-time PCR, Digital PCR & End-point PCR Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Product
8.3.5.2.3. By Application
9. MIDDLE EAST & AFRICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.2. UAE Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.3. South Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Product
9.3.3.2.3. By Application
10. SOUTH AMERICA REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Product
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.2. Colombia Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.3. Argentina Real-time PCR, Digital PCR & End-point PCR Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Product
10.3.3.2.3. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL REAL-TIME PCR, DIGITAL PCR & END-POINT PCR MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Bio-Rad Laboratories Inc.
15.3. Thermo Fisher Scientific, Inc.
15.4. BIOMERIEUX SA
15.5. Fluidigm Corporation
15.6. F. Hoffmann-La Roche Ltd
15.7. GE Healthcare
15.8. Agilent Technologies, Inc.
15.9. Qiagen NV
15.10. Microsynth Ag
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
